Abstract
Objective: To explore the therapeutic effect of alternating red and blue light irradiation combined with collagen in patients with acne vulgaris and the risk factors of short-term recurrence. Method: A retrospective analysis was conducted on 105 patients with acne vulgaris treated in Baoji Hospital of Traditional Chinese Medicine from January 2019 to February 2020. 50 patients received conventional treatment (Pumen red and blue light) were taken as the control group, and the other 55 patients treated with collagen dressing on the basis of control group were taken as the research group. Clinical efficacy, changes of serum interleukin-1β (IL-1β) and interleukin-6 (IL-6) before and after treatment, and the occurrence of adverse reactions were compared between the two groups of patients. The scores of inflammatory skin lesions, facial seborrhea scores, stratum corneum water content and transepidermal water loss (TEWL) were compared before and after the treatment. The 1-year review records of patients were queried, and they were divided into a relapse group and a non-relapse group according to the recurrence situation. Logistic regression was used to analyze the risk factors affecting the recurrence of the patients. Results: The clinical efficacy of the patients in research group after treatment was significantly higher than that in the control group (P<0.05). IL-1β and IL-6 in the serum of patients after treatment were markedly decreased, and such decline in the research group was more evident after treatment (P<0.05). The incidence of adverse reactions, the scores of inflammatory skin lesions, and facial seborrhea and TEWL in the research group after treatment were all lower than those in the control group (all P<0.05), while the water content of the stratum corneum was higher comparatively (P<0.05). 17 patients were confirmed with recurrence within 1 year after treatment. Logistic regression analysis found that age, monthly income, pre-treatment IL-1β and pre-treatment IL-6 were risk factors for recurrence. Conclusion: Alternating red and blue light irradiation combined with collagen can improve the treatment efficacy in patients with acne vulgaris. And indexes like age, monthly income, pre-treatment IL-1β and pre-treatment IL-6 are risk factors affecting the recurrence of patients.
Keywords: Red and blue light, collagen patch, acne vulgaris, short-term recurrence, risk factors
Introduction
Acne vulgaris is a common dermatological disease in adolescence and often lasts into adulthood. Only a small number of patients over 30 have trouble in recovering [1]. The exact mechanism of acne has not been fully confirmed currently, but most studies claimed that excessive keratinization of hair follicle epithelium, excessive secretion of sebaceous glands, and inflammatory reactions increase the incidence of acne [2]. It is believed that the causes of acne vulgaris include hyperactivation of androgen receptors in sebocytes to stimulate sebum production, abnormal keratinization of pilosebaceous ducts, proliferation of P. acnes, inflammation and immune responses [3]. Past survey has shown that acne vulgaris was a common disfiguring skin disease with high incidence [4]. Another one [5] revealed that the incidence of acne in the Chinese population is above 80%, with repetitive course of disease and long duration. Post-inflammatory hyperpigmentation or even permanent scars may be left in severe cases, causing greater psychological pressure and economic burden to patients, especially to adolescents.
There are great differences in the selection of acne treatment, and the efficacy of some treatment methods is uncertain and lacks support of evidence-based medicine [6]. In recent years, more and more studies have been conducted on the interaction between laser and tissue, including research on bacterial colonization of the epidermis, sebaceous gland function, and porphyrin metabolism. A series of new lasers and light source equipment have emerged for acne treatment [7]; red and blue light irradiation treatment is found to be one of those to repair inflammatory acne and relieve sunburn with good efficacy [8]. Single application of that, however, will cause different degrees of skin burning, dryness, flushing and other adverse symptoms [9]. Collagen has the functions of moisturizing, whitening, anti-wrinkle, freckle removal, etc., which can be extensively applied in beauty products to improve the microcirculation of epidermal cells, promote skin tissue metabolism, and accelerate skin tissue regeneration and repair [10]. However, the factors affecting the short-term efficacy and recurrence after the combined irradiation and collagen treatment are still up for debate.
In this study, we aimed to analyze the therapeutic effect of combined treatment of alternating red and blue light and collagen on patients with acne vulgaris and the risk factors for its short-term recurrence, so as to provide a reference for the clinical treatment of acne vulgaris.
Methods and treatments
Clinical information
A retrospective analysis was conducted on 105 patients with acne vulgaris treated in Baoji Hospital of Traditional Chinese Medicine from January 2019 to February 2020. 50 patients received conventional treatment (Pumen red and blue light) were taken as the control group (CG), and the other 55 patients treated with additional collagen dressing on the basis of CG were taken as the research group (RG). This study was conducted under the approval of the Medical Ethics Committee of Baoji Hospital of Traditional Chinese Medicine (Ethical approval number: BJSZYYY-LWFB-20220905).
Inclusive and exclusion criteria
Inclusion criteria
Patients in line with relevant diagnostic and grading criteria of the “Acne Treatment Guidelines” [11]; patients with no cognitive impairment; patients with good communication skills; patients with complete clinical data.
Exclusion criteria
Patients with recent retinoic acid or antibiotics treatments; patients with light-sensitive skin diseases; patients with severe liver and kidney insufficiency; patients with systemic infection, skin cancer, or mental illness; patients in pregnancy or breastfeeding; patients with allergy to foreign proteins; patients unwilling to cooperate with treatment; patients with intolerance to the treatment method of present study; patients with scar constitution; patients with facial infection.
Instruments and medicines
Common red and blue light: Product model: Carnation-88C, blue light intensity specification: ≥100 mW/cm2 (light outlet center), wavelength specification: 460 nm ± 10 nm, energy level: 3; Red light intensity specification: ≥100 mW/cm2 (light output mouth center), wavelength specification: 640 nm ± 10 nm, energy level: level 5, irradiation distance: 15-20 cm (Serial number: C88C18C00207; Manufacturer: Shenzhen Pumen Technology Co., Ltd.). Collagen dressing (Guangzhou Chuanger Biological Co., Ltd., 20172640686)
Severity classification of patients
Grade 1: mild acne, mainly manifested as sporadic or multiple blackheads and pimples, which may be accompanied by scattered inflammatory papules; Grade 2: moderate acne, mainly on the basis of first-degree acne with increased number of inflammatory skin lesions and small superficial pustules, of which the inflammation is merely distributed on the face; Grade 3: severe acne, mainly second-degree acne plus deep pustules, principally distributed on the face, neck and chest and back.
Treatment plan
Patients in CG were treated with conventional treatment specifically as follows: before treatment, the skin of patient was thoroughly cleaned, photographed and archived, with eyes protected with goggles during treatment. Then, alternating red and blue light was conducted, with the treatment unit placed above patient’s face and light positioning distance kept at 1-4 cm. Blue light was applied first, then red light. For mild cases, only blue light was used. The treatment was continued for 8 weeks.
Patients in RG were treated with collagen dressings on the basis of CG treatment. Moderate and severe cases were treated with blue-red light irradiation combined with collagen dressings. During the first week of alternating red and blue light therapy, the wound surface was managed once a day, and from the 2nd to the 8th week, it was applied at intervals; mild patients were applied with single blue light combined with collagen dressing.
Inflammatory lesion score
Before each treatment, the patient’s front and side were photographed with a high-definition camera, and the acne on the cheek, forehead, and nasal area was carefully observed by the same two dermatologists, and the pustules, erythema, cysts and inflammatory lesions such as papules were scored. Lesion pain, color change, type and number of skin lesions were scored 3 points each, with a total score of 12 points. Higher scores indicate more severe inflammatory skin lesions [12].
Facial seborrhea score
After facial cleaning, the patient was required to wait for 30 minutes in a test room (25°C, 50% humidity). The SebumeterSM815 skin oil measuring instrument provided by German CK Company was used to measure the degree of facial oil spillage, with a total score of 10. The more severe the facial seborrhea, the higher the score [13].
Stratum corneum hydration
CM825 skin physiology detector (Courage + Khazaka Electronic GmbH, Germany) was used to detect the left and right cheeks three times by means of continuous contact measurement, and the average value was taken to express the facial skin moisture content in percentage.
Transepidermal water loss (TEWL)
The skin physiology detector (1.5.3) was utilized for water loss detection. The probe was placed on the highest part of the cheekbones, TEWL value within 10 s was then read and the average value was calculated.
Serological index detection
Serum interleukin-1β and interleukin-6 levels were detected by Enzyme linked immunosorbent assay (Elisa). The kit was from Shanghai Biyuntian Biotechnology Co., Ltd.
Observation indicators
Main outcome measures
The clinical efficacy in the two groups of patients was compared and categorized as follows: recovery (with skin lesions reduction ≥90%), markedly effective (with skin lesions reduction ≥60%), effective (with skin lesions reduction ≥20%), and ineffective (with skin lesions reduction <20%). Total effective rate = (markedly effective + effective)/total number of cases × 100%. Inflammatory skin lesion scores, facial seborrhea scores, stratum corneum water content and TEWL were compared before and after treatment. The 1-year review records of the patients were queried, and they were grouped into relapse group and non-relapse group, and logistic regression was applied to analyze the risk factors affecting patients’ recurrence.
Secondary observation indicators
Clinical data of the two groups of patients were compared, including changes of IL-1β and IL-6 before and after treatment, and the occurrence of adverse reactions.
Statistical analysis
All data collected were statistically calculated using SPSS 20.0, and visualized using Graph Pad Prism 8. Enumeration data were analyzed by the chi-square test. Measurement data were expressed as mean ± standard deviation. Among them, inter-group comparison and intra-group comparison were analyzed by Student t-test and paired t-test, respectively. Kaplan-Meier (K-M) was taken to analyze the recurrence of patients, logistic regression was used to analyze the risk factors of recurrence in patients with acne vulgaris, and the receiver operating curve (ROC) was drawn to analyze the value of risk factors in predicting the recurrence of patients. P<0.05 was taken as the significance level.
Results
Baseline information
Subjects were comparable due to insignificant differences observed regarding gender, age, course of disease, acne severity, education level, monthly income, smoking history, and alcoholism history between the two groups (all P>0.05, Table 1).
Table 1.
Baseline information
Indicators | Control group (n = 50) | Research group (n = 55) | χ2 | P |
---|---|---|---|---|
Age | 0.948 | 0.330 | ||
≥20 years old | 30 | 38 | ||
<20 years ole | 20 | 17 | ||
Gender | 0.349 | 0.554 | ||
Male | 21 | 20 | ||
Female | 29 | 35 | ||
Course of disease | 0.292 | 0.588 | ||
≥2 years | 33 | 39 | ||
<2 years | 17 | 16 | ||
Acne severity | 0.998 | 0.606 | ||
Grade I | 18 | 25 | ||
Grade II | 22 | 20 | ||
Grade III | 10 | 10 | ||
Education level | 2.829 | 0.092 | ||
≥Senior High School | 30 | 45 | ||
<Senior High School | 20 | 15 | ||
Monthly income | 0.216 | 0.641 | ||
≥5000 RMB | 25 | 30 | ||
<5000 RMB | 25 | 25 | ||
Smoking history | 0.021 | 0.883 | ||
YES | 13 | 15 | ||
NO | 37 | 40 | ||
History of alcoholism | 0.498 | 0.480 | ||
YES | 5 | 8 | ||
NO | 45 | 47 |
Comparison of therapeutic effect of patients
Comparing the clinical efficacy of two groups after treatment, it was found that RG held an evidently higher total rate of clinical efficacy compared to CG (P = 0.017, Table 2).
Table 2.
Comparison of clinical efficacy between the two groups
Grouping | Recovery | Markedly effective | Effective | Ineffective | Total effective rate |
---|---|---|---|---|---|
Control group (n = 50) | 12 (24.00) | 18 (36.00) | 7 (14.00) | 12 (24.00) | 38 (76.00) |
Research group (n = 55) | 25 (45.45) | 20 (36.36) | 6 (10.91) | 4 (7.28) | 55 (92.72) |
χ2 | 5.674 | ||||
P | 0.017 |
Changes of serum IL-1β and IL-6 in patients before and after treatment
After treatment, IL-1β and IL-6 of the two groups of patients both went markedly lower than those before treatment (both P<0.05), and levels of those in RG were obviously lower than those in CG (both P<0.05, Figure 1).
Figure 1.
Changes of serum IL-1β and IL-6 levels in patients before and after treatment. A. Changes of IL-1β levels in the two groups before and after the treatment. B. Changes of IL-6 levels in the two groups before and after the treatment. Note: *** means P<0.001. IL-1β: interleukin-1β; IL-6: interleukin-6.
Comparison of adverse reactions in patients
The adverse reactions of the two groups of patients were counted, and they were found to be evidently higher in CG than in RG (P = 0.023, Table 3).
Table 3.
Comparison of adverse reactions between the two groups
Grouping | Mild redness | Facial tightness | Erythema | Ache | Exudation | Total incidence |
---|---|---|---|---|---|---|
Control group (n = 50) | 2 (4.00) | 2 (4.00) | 2 (4.00) | 2 (4.00) | 2 (4.00) | 10 (20.00) |
Research group (n = 55) | 1 (1.82) | 1 (1.82) | 0 (0.00) | 0 (0.00) | 1 (1.82) | 3 (5.46) |
χ2 | 5.108 | |||||
P | 0.023 |
Changes of skin physiological indexes and symptom scores before and after treatment
After treatment, the inflammatory skin lesion score, facial seborrhea score and TEWL of RG were lower than those of CG, while its hydration of the stratum corneum was higher comparatively (Figure 2, P<0.05).
Figure 2.
Changes of skin physiological indexes and symptom scores of patients before and after treatment. A. Changes of inflammatory lesion score in the two groups before and after treatment. B. Changes of facial seborrhea score in the two groups before and after treatment. C. Changes of stratum corneum hydration in the two groups before and after treatment. D. Changes of transepidermal water loss in the two groups before and after treatment. Note: ** means P<0.01, *** means P<0.001.
Statistics on recurrence
By querying the 1-year outpatient records and electronic medical records, we found that 17 patients had recurrence, including 10 patients in the control group and 7 patients in the research group, and no statistical difference was observed between the two groups (P = 0.312, Table 4). In addition, K-M curve analysis found that there was no statistical difference in recurrence between the two groups (P = 0.346, Figure 3).
Table 4.
Recurrence of the two groups of patients
Grouping | Relapse | Non-relapse |
---|---|---|
Control group (n = 50) | 10 | 40 |
Research group (n = 55) | 7 | 48 |
χ2 | 1.021 | |
P | 0.312 |
Figure 3.
Statistics of recurrence of patients after treatment.
Analysis of risk factors affecting recurrence in patients
The patients were grouped according to their relapse status. Through univariate analysis, it was found that age, gender, monthly income, pre-treatment IL-1β and pre-treatment IL-6 were the factors affecting the recurrence of patients (Table 5). In order to further analyze the results (Table 6), we then conducted multivariate logistic regression analysis and found that age, monthly income, pre-treatment IL-1β and pre-treatment IL-6 were independent risk factors for recurrence (P<0.05, Tables 6, 7).
Table 5.
Univariate analysis of the factors affecting the acne recurrence
Indicators | Relapse group (n = 17) | Non-relapse group (n = 88) | χ2/t | P |
---|---|---|---|---|
Age | 7.718 | 0.005 | ||
≥20 years old | 6 | 62 | ||
<20 years old | 11 | 26 | ||
Gender | 5.611 | 0.017 | ||
Male | 11 | 30 | ||
Female | 6 | 58 | ||
Course of disease | 0.038 | 0.844 | ||
≥2 years | 12 | 60 | ||
<2 years | 5 | 28 | ||
Acne severity | 1.415 | 0.493 | ||
Grade I | 6 | 37 | ||
Grade II | 6 | 36 | ||
Grade III | 5 | 15 | ||
Education level | 0.811 | 0.367 | ||
≥Senior High School | 10 | 65 | ||
<Senior High School | 7 | 28 | ||
Monthly income | 6.769 | 0.009 | ||
≥5000 RMB | 4 | 51 | ||
<5000 RMB | 13 | 37 | ||
Smoking history | 0.078 | 0.779 | ||
YES | 5 | 23 | ||
NO | 12 | 65 | ||
History of alcoholism | 0.518 | 0.471 | ||
YES | 3 | 10 | ||
NO | 14 | 78 | ||
Before treatment IL-1β (pg/mL) | 257.21±12.60 | 246.21±16.48 | 2.603 | 0.010 |
Before treatment IL-6 (pg/mL) | 191.27±7.51 | 183.46±9.87 | 3.088 | 0.002 |
Table 6.
Assignment table
Factors | Assignment |
---|---|
Age | Belonging to continuous variables using raw data analysis |
Gender | Male = 1, Female = 0 |
Monthly income | ≥5000 yuan = 1, <5000 yuan = 0 |
Before treatment IL-1β | Belonging to continuous variables using raw data analysis |
Before treatment IL-6 | Belonging to continuous variables using raw data analysis |
Recurrence | Recurrence = 1, No recurrence = 0 |
Table 7.
Multivariate logistic regression analysis of the factors affecting the acne recurrence
Factors | β | SE | χ2 | P | OR | 95% CI | |
---|---|---|---|---|---|---|---|
| |||||||
Lower limit | Upper limit | ||||||
Age | -0.11 | 0.05 | 4.778 | 0.029 | 0.896 | 0.812 | 0.989 |
Gender | 0.988 | 0.666 | 2.204 | 0.138 | 2.686 | 0.729 | 9.904 |
Monthly income | -1.476 | 0.687 | 4.612 | 0.032 | 0.229 | 0.059 | 0.879 |
Before treatment IL-1β | 0.053 | 0.023 | 5.511 | 0.019 | 1.055 | 1.009 | 1.103 |
Before treatment IL-6 | 0.093 | 0.038 | 5.938 | 0.015 | 1.097 | 1.018 | 1.182 |
Clinical value of risk factors in predicting acne recurrence
According to the results of risk factors, we drew the ROC curves of age, monthly income, IL-1β before treatment, and IL-6 before treatment in predicting acne recurrence and found that the areas under the curve (AUCs) were 0.687, 0.670, 0.707, and 0.730, respectively. Among them, the AUC of IL-1β and IL-6 before treatment exceeding 0.7 has certain clinical value (Figure 4; Table 8).
Figure 4.
ROC curve of risk factors in predicting acne recurrence.
Table 8.
ROC parameters
Factors | Area under the curve | Confidence interval | Specificity | Sensitivity | Youden index |
---|---|---|---|---|---|
Age | 0.687 | 0.537-0.837 | 0.647 | 0.736 | 0.383 |
Monthly income | 0.670 | 0.553-0.786 | 0.765 | 0.575 | 0.339 |
Before treatment IL-1β | 0.707 | 0.594-0.821 | 0.824 | 0.598 | 0.421 |
Before treatment IL-6 | 0.730 | 0.622-0.838 | 0.941 | 0.506 | 0.447 |
Discussion
Acne vulgaris is a common chronic inflammatory disease involving the pilosebaceous glands [14]. Retinoids or antibiotics were commonly used for the treatment, but the clinical effect was not noteworthy due to factors like long treatment, bacterial resistance and various adverse reactions [15]. Therefore, there is a strong need to find safer and more effective treatment methods to improve the degree of skin lesions in patients.
In this study, it was confirmed that alternating red and blue light irradiation combined with collagen effectively improved the treatment efficacy in patients with acne vulgaris, as well as the changes of skin physiological indicators and symptom scores, and reduced the incidence of adverse events. Red and blue light irradiation promotes the synthesis of adenosine triphosphate (ATP) through actinic action, increases cell metabolism, promotes cell proliferation, accelerates the release of growth factors, improves local blood circulation, and promotes local repair of fibroblasts, thereby promoting wound healing to a certain extent [16]. Collagen patch, a moisturizing dressing made of collagen stock solution and non-woven fabric, is suitable for skin in sub-healthy state and has the ability to quickly restore the water retention capacity of the stratum corneum [17]. What’s more, studies have also found that collagen dressings could promote cell differentiation, movement, chemotaxis and repair of connective tissue; it was convenient for leukocyte mediators to mediate the role of phagocytes, increase local bacterial power, and improve the speed of epidermal regeneration [18,19]. In the study of Nitayavardhana et al. [20], it was found that alternating red and blue light evidently ameliorated the inflammation in patients with moderate and severe acne vulgaris. Another one by Kharazi et al. [21] also claimed that patients’ conditions was obviously improved after the therapy. Consequently, we speculated that red and blue light irradiation could kill Propionibacterium acnes in the pilosebaceous glands to the maximum extent, and collagen, on the other hand, could promote skin wound healing and reduce adverse reactions such as flushing, burning, and dryness in patients. Apart from that, it could also improve the blood circulation of the skin, and maintain the moisture of the stratum corneum and the integrity of fiber structure. We believe the combination of the two has synergistic effect and improves the therapeutic effect.
Cytokines IL-1β and IL-6, mainly produced by monocytes-macrophages, are the key substances to initiate immune response. The levels of them in skin lesions can serve as reliable indicators to reflect the state of skin inflammation [22-24]. In the study of Ahmed et al. [25], it was concluded that serum levels of IL-6 and tumor necrosis factor (TNF-α) were evidently reduced in patients treated with active vitamin D. In our study, we compared the levels of IL-1β and IL-6 of patients before and after intervention, and found that they were markedly reduced in both groups after treatment, yet RG held an even lower level compared to CG. This suggested that the combined treatment of red and blue light and collagen dressing had the effect of improving inflammation in patients just as active vitamin D did. When the blue light source is irradiated on the surface of the patient’s skin, it can accelerate the growth of endothelial cells and fibroblasts in the affected area, reduce the inflammatory response in the local area, and thus play a therapeutic effect.
Recurrence of acne vulgaris is commonly seen in clinical practice [26]. We compared the recurrence rates of two groups in this study and found no evident difference in terms of recurrence rates after treatment. But in attempts to further identify the risk factors affecting relapse in patients, we conducted a systematic analysis and found that age, monthly income, pre-treatment IL1β and pre-treatment IL-6 were risk factors for relapse. Endocrine disorders are prone to occur among young patients because they are in the period of physical development. At this stage, hormones normally increase and very likely promote active sebum secretion, thereby leading to the recurrence of disease, which was previously confirmed in the study of Quéreux et al. [27]. Interestingly, what we found was that high monthly income was a protective factor for the recurrence of acne vulgaris, which was mainly because high-income people have higher requirements for self-generated appearance, and are able to afford more skin care products. In addition, high levels of pre-treatment inflammatory factors may also affect patient relapse, as inflammation is an important part of the pathogenesis of ulcers [28]. There is a specific immune response observed in acne vulgaris patients that can be involved in the pathogenic process of acne and promote the formation of acne inflammation. And it is acknowledged that abnormal up-regulation of inflammatory factors induces the occurrence of acne. Therefore, effectively controlling the inflammatory response in patients is an effective means to improve acne vulgaris [29]. At the end of the study, we analyzed the value of age, monthly income, pre-treatment IL-1β and pre-treatment IL-6 in predicting relapse in patients. Through ROC curve analysis, it was found that the AUCs of IL1β and IL-6 before treatment were all greater than 0.7, which were good clinical predictors.
In this study, we determined through statistical analysis that alternating red and blue light irradiation combined with collagen application could improve the treatment efficacy in patients with acne vulgaris, and that age, monthly income, pre-treatment IL-1β and pre-treatment IL-6 were all risk factors for recurrence. However, this study still has some limitations. First, due to the nature of retrospective study, we failed to follow up patients in long-term. Second, research samples were not as homogeneous as randomized controlled trials. Therefore, we hope to carry out more experiments and long-term follow-up in future studies to refine our conclusions.
To sum up, alternating red and blue light irradiation combined with collagen dressing can improve the treatment efficacy in patients with acne vulgaris, and factors such as age, monthly income, pre-treatment IL-1β and pre-treatment IL-6 were risk factors affecting the recurrence of patients.
Acknowledgements
Health research project of Shaanxi Province (No. 2022D015).
Disclosure of conflict of interest
None.
References
- 1.Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP. Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin. 2012;30:99–106. doi: 10.1016/j.det.2011.09.001. [DOI] [PubMed] [Google Scholar]
- 2.Habeshian KA, Cohen BA. Current issues in the treatment of acne vulgaris. Pediatrics. 2020;145(Suppl 2):S225–S230. doi: 10.1542/peds.2019-2056L. [DOI] [PubMed] [Google Scholar]
- 3.Harper JC. Acne vulgaris: what’s new in our 40th year. J Am Acad Dermatol. 2020;82:526–527. doi: 10.1016/j.jaad.2019.01.092. [DOI] [PubMed] [Google Scholar]
- 4.Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10:5754. doi: 10.1038/s41598-020-62715-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Yang J, Yang H, Xu A, He L. A review of advancement on influencing factors of acne: an emphasis on environment characteristics. Front Public Health. 2020;8:450. doi: 10.3389/fpubh.2020.00450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment modalities for acne. Molecules. 2016;21:1063. doi: 10.3390/molecules21081063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Soliman YS, Horowitz R, Hashim PW, Nia JK, Farberg AS, Goldenberg G. Update on acne scar treatment. Cutis. 2018;102:21. [PubMed] [Google Scholar]
- 8.Salavastru C, Tiplica GS, Branisteanu DE, Fritz K. Light-based inflammatory acne treatments. Hautarzt. 2018;69:27–34. doi: 10.1007/s00105-017-4099-9. [DOI] [PubMed] [Google Scholar]
- 9.Li WH, Fassih A, Binner C, Parsa R, Southall MD. Low-level red LED light inhibits hyperkeratinization and inflammation induced by unsaturated fatty acid in an in vitro model mimicking acne. Lasers Surg Med. 2018;50:158–165. doi: 10.1002/lsm.22747. [DOI] [PubMed] [Google Scholar]
- 10.Gong EY, Lee S, Park S, Kim KE, Kim MS, Kim D, Park HJ, Cho D. Erythroid differentiation regulator 1 (Erdr1) enhances wound healing through collagen synthesis in acne skin. Arch Dermatol Res. 2020;312:59–67. doi: 10.1007/s00403-019-01980-3. [DOI] [PubMed] [Google Scholar]
- 11.Thiboutot DM, Dreno B, Abanmi A, Alexis AF, Araviiskaia E, Barona Cabal MI, Bettoli V, Casintahan F, Chow S, da Costa A, El Ouazzani T, Goh CL, Gollnick HPM, Gomez M, Hayashi N, Herane MI, Honeyman J, Kang S, Kemeny L, Kubba R, Lambert J, Layton AM, Leyden JJ, Lopez-Estebaranz JL, Noppakun N, Ochsendorf F, Oprica C, Orozco B, Perez M, Piquero-Martin J, See JA, Suh DH, Tan J, Lozada VT, Troielli P, Xiang LF. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(Suppl 1):S1–23. doi: 10.1016/j.jaad.2017.09.078. [DOI] [PubMed] [Google Scholar]
- 12.Kim B, Kim KI, Lee J, Kim K. Inhibitory effects of Cheongsangbangpoong-tang on both inflammatory acne lesion and facial heat in patients with acne vulgaris: a double-blinded randomized controlled trial. Complement Ther Med. 2019;44:110–115. doi: 10.1016/j.ctim.2019.03.018. [DOI] [PubMed] [Google Scholar]
- 13.Gupta AK, Versteeg SG. Topical treatment of facial seborrheic dermatitis: a systematic review. Am J Clin Dermatol. 2017;18:193–213. doi: 10.1007/s40257-016-0232-2. [DOI] [PubMed] [Google Scholar]
- 14.Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA. 2021;326:2055–2067. doi: 10.1001/jama.2021.17633. [DOI] [PubMed] [Google Scholar]
- 15.Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2021;32:277–285. doi: 10.1080/09546634.2019.1654075. [DOI] [PubMed] [Google Scholar]
- 16.Babaee A, Nematollahi-Mahani SN, Shojaei M, Dehghani-Soltani S, Ezzatabadipour M. Effects of polarized and non-polarized red-light irradiation on proliferation of human Wharton’s jelly-derived mesenchymal cells. Biochem Biophys Res Commun. 2018;504:871–877. doi: 10.1016/j.bbrc.2018.09.010. [DOI] [PubMed] [Google Scholar]
- 17.Liu D, Nikoo M, Boran G, Zhou P, Regenstein JM. Collagen and gelatin. Annu Rev Food Sci Technol. 2015;6:527–557. doi: 10.1146/annurev-food-031414-111800. [DOI] [PubMed] [Google Scholar]
- 18.Bielajew BJ, Hu JC, Athanasiou KA. Methodology to quantify collagen subtypes and crosslinks: application in minipig cartilages. Cartilage. 2021;13(Suppl):1742S–1754S. doi: 10.1177/19476035211060508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Meyer M. Processing of collagen based biomaterials and the resulting materials properties. Biomed Eng Online. 2019;18:24. doi: 10.1186/s12938-019-0647-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nitayavardhana S, Manuskiatti W, Cembrano KAG, Wanitphadeedecha R. A comparative study between once-weekly and alternating twice-weekly regimen using blue (470 nm) and red (640 nm) light combination LED phototherapy for moderate-to-severe acne vulgaris. Lasers Surg Med. 2021;53:1080–1085. doi: 10.1002/lsm.23388. [DOI] [PubMed] [Google Scholar]
- 21.Kharazi L, Dadkhahfar S, Rahimi H, Gheisari M, Mozafari N, Tehranchinia Z. The efficacy of blue light versus the combination of blue and red light therapy in the treatment of acne vulgaris. Photodermatol Photoimmunol Photomed. 2021;37:564–566. doi: 10.1111/phpp.12702. [DOI] [PubMed] [Google Scholar]
- 22.Li N, Wang JX, Huo TT, Zhao JR, Wang TJ. Associations of IL-1beta and IL-6 gene polymorphisms with Parkinson’s disease. Eur Rev Med Pharmacol Sci. 2021;25:890–897. doi: 10.26355/eurrev_202101_24657. [DOI] [PubMed] [Google Scholar]
- 23.Cui G, Yuan A, Sun Z, Zheng W, Pang Z. IL-1beta/IL-6 network in the tumor microenvironment of human colorectal cancer. Pathol Res Pract. 2018;214:986–992. doi: 10.1016/j.prp.2018.05.011. [DOI] [PubMed] [Google Scholar]
- 24.Hirano S, Zhou Q, Furuyama A, Kanno S. Differential regulation of IL-1beta and IL-6 release in murine macrophages. Inflammation. 2017;40:1933–1943. doi: 10.1007/s10753-017-0634-1. [DOI] [PubMed] [Google Scholar]
- 25.Ahmed Mohamed A, Salah Ahmed EM, Abdel-Aziz RTA, Eldeeb Abdallah HH, El-Hanafi H, Hussein G, Abbassi MM, El Borolossy R. The impact of active vitamin D administration on the clinical outcomes of acne vulgaris. J Dermatolog Treat. 2021;32:756–761. doi: 10.1080/09546634.2019.1708852. [DOI] [PubMed] [Google Scholar]
- 26.Tan TH, Hallett R, Yesudian PD. Efficacy and relapse rates of different isotretinoin dosages in treating acne vulgaris: systemic review. Clin Med (Lond) 2016;16(Suppl 3):s34. doi: 10.7861/clinmedicine.16-3-s34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Quereux G, Volteau C, N’Guyen JM, Dreno B. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology. 2006;212:168–176. doi: 10.1159/000090658. [DOI] [PubMed] [Google Scholar]
- 28.Dreno B, Dagnelie MA, Khammari A, Corvec S. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21:18–24. doi: 10.1007/s40257-020-00531-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tan JKL, Stein Gold LF, Alexis AF, Harper JC. Current concepts in acne pathogenesis: pathways to inflammation. Semin Cutan Med Surg. 2018;37:S60–S62. doi: 10.12788/j.sder.2018.024. [DOI] [PubMed] [Google Scholar]